Cross Country Healthcare CCRN Cash Flow Statement (2010-2026)

NASDAQ CCRN
$13.25 +0.00 (+0.00%)
At close: Jul 28, 2026 · 4:00 PM EDT
Reported Financials

Cross Country Healthcare Quarterly Cash Flow Statement

Periods 64 quarters
Latest Mar 2026

Cross Country Healthcare reported cash from operations of $4.77M and free cash flow of $3.31M for the quarter ended Mar 2026, down 16.1% year over year. This cash flow statement covers 64 quarters of results from Jun 2010 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income
11.55M23.43M77.57M61.98M52.89M34.79M36.31M29.44M21.34M12.81M9.04M2.69M-16.05M2.56M-3.75M-0.49M-6.66M-4.77M-82.93M-4.27M
Share-based CompensationStock Comp.
1.46M1.77M1.64M5.03M0.24M2.13M4.51M0.37M0.53M1.17M2.71M0.75M0.87M1.70M1.32M0.87M0.77M4.19M1.17M
Deferred Taxes
2.66M-0.13M-12.72M2.43M1.05M-0.68M2.31M-0.60M0.11M1.12M0.67M-0.81M-3.23M1.09M1.00M-0.68M0.62M-1.24M11.37M0.22M
Gains from Investment SecuritiesGains Investment
Asset Writedowns and ImpairmentWritedown
1.90M1.44M2.37M2.37M3.19M1.10M2.95M4.91M3.13M2.35M4.17M1.29M18.86M1.51M-0.23M0.04M0.03M-0.86M0.35M0.23M
Cash from OperationsCash from Ops.
15.51M-2.83M-73.36M-29.04M18.14M140.63M4.32M46.87M119.25M70.31M12.07M6.01M82.40M7.47M24.23M5.68M4.22M20.11M18.24M4.77M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
Amortization of Deferred ChargesAmort. Deferred Charges
Depreciation & Amortization (CF)Dep. & Amort.
2.20M2.68M2.72M2.72M3.48M3.21M3.16M4.90M4.43M4.54M4.47M4.64M4.72M4.50M4.34M4.77M4.10M4.09M3.83M3.67M
Change in Working Capital
Change in ReceivablesChange Receivables
-0.31M46.61M195.53M186.70M28.53M-88.23M26.23M-7.89M-138.56M-70.78M-34.20M-13.72M-96.21M4.08M-22.47M-3.58M-18.29M-22.45M-12.40M9.04M
Change in Accured ExpensesChange Accured Exp.
-4.49M14.66M46.61M62.98M15.46M8.72M-4.22M-11.99M-54.56M-23.05M-37.02M-15.49M-17.77M-0.33M3.84M-9.17M-12.68M-3.45M-9.27M13.63M
Change in TaxesChange Taxes
-0.14M0.28M6.73M22.05M-31.07M-4.20M-7.69M9.90M-1.56M-0.41M-0.97M1.29M-2.33M0.09M-1.33M4.55M0.66M1.73M0.23M0.55M
Investing Activities
Capital ExpendituresCapex
1.82M1.89M2.28M2.10M1.75M2.92M2.02M3.68M4.00M3.42M2.88M2.21M2.85M1.12M2.53M1.89M1.97M2.19M2.12M1.46M
Acquisitions
3.50M35.18M
Divestments
Cash from Investing ActivitiesCash from Investing
-26.29M-1.89M-4.69M-2.10M-1.75M-2.92M-37.11M-3.50M-4.00M-3.41M-2.88M-2.21M-2.85M-1.12M-2.53M-1.89M-1.97M-2.19M-2.12M-1.46M
Financing Activities
Other financing activitiesOther financing
-0.01M-0.22M-0.01M-0.01M-0.51M-0.01M-0.51M-0.01M-0.50M
Cash from Financing ActivitiesCash from Financing
15.43M-12.57M78.22M31.31M-17.32M-107.66M6.08M-46.68M-114.87M-53.27M-6.42M-15.65M-15.19M-11.93M-4.08M-4.72M-1.76M-0.01M-6.52M-6.46M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
Dividend Payments
Dividends Paid - CommonDiv. Paid (Common)
0.21M
Additional items
Exchange Rate EffectFX Effect
-0.01M0.00M0.02M-0.00M0.00M-0.01M-0.00M0.00M-0.00M0.01M-0.01M-0.01M0.00M0.02M0.00M-0.01M
Change in Cash
4.64M-17.29M0.19M0.17M-0.93M30.04M-26.72M-3.31M0.38M13.63M2.79M-11.85M64.36M-5.58M17.61M-0.94M0.50M17.94M9.61M-3.15M
Free Cash FlowFCF
13.69M-4.72M-75.64M-31.13M16.39M137.71M2.30M43.19M115.25M66.89M9.20M3.80M79.55M6.35M21.70M3.79M2.25M17.92M16.12M3.31M
Net Cash FlowNCF
4.65M-17.29M0.17M0.17M-0.93M30.05M-26.72M-3.31M0.38M13.63M2.78M-11.85M64.36M-5.58M17.63M-0.93M0.49M17.92M9.60M-3.15M